Journals / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 2

The Assessment of Volume Status with Body CompositionMonitor in Cancer Patients

Pages
246–250
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Also according to baseline, serum levels of Na, K, Ca,and body weight were decreased (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Intravenous (IV) fluid therapy is often needed in patients with the malignant disease during IV chemotherapy.
📊
Key Findings & Data:Methods: Thirty chemotherapy cycles of the 30 cancer patients were evaluated.
💡
Conclusion & Impact:Also according to baseline, serum levels of Na, K, Ca,and body weight were decreased (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Intravenous (IV) fluid therapy is often needed in patients with the malignant disease during IV chemotherapy. The aim of our study is to evaluate the volume status of cancer patients treated with IV chemotherapy andstandard fluid therapy by using body composition monitor (BCM) measurements. Methods: Thirty chemotherapy cycles of the 30 cancer patients were evaluated. Patients had solid tumors (10.7%) andlymphoproliferative disease (89.3%). Biochemical and hematological parameters and fluid status by using BCM weremeasured on the 1st and fifth days of chemotherapy cycles. Results: Hypovolemia or hypervolemia were found both at baseline and 5. day during IV fluid and chemotherapy incancer patients (1.057±1.68 and 0.78±1.63 p>0.05 respectively). Also according to baseline, serum levels of Na, K, Ca,and body weight were decreased (p

🔖

Cite This Article

PAYDAŞ, S., KAYA, B., PAYDAŞ, S., ÖZONUR, H., EFE, C. (2022). The Assessment of Volume Status with Body CompositionMonitor in Cancer Patients. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 2, 246–250. https://ajindex.com/articles/508617

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Keane DF, Bowra K, Kearney K, Lindley E. Use of the Body Composition Monitor for Fluid Status Measurements in Elderly Malnourished Subjects. ASAIO J 2017;63:507–11
  2. Piccoli A. Bioelectric impedance measurement for fluid status assessment. Contrib Nephrol 2010;164:143–52
  3. Toso S, Piccoli A, Gusella M, Menon D, Crepaldi G, Bononi A, et al. Bioimpedance vector pattern in cancer patients without disease versus locally advanced or disseminated disease. Nutrition 2003;19:510–4
  4. Piccoli A; Italian CAPD-BIA Study Group. Bioelectric impedance vector distribution in peritoneal dialysis patients with different hydration status. Kidney Int 2004;65:1050–63
  5. Małecka-Massalska T, Chara K, Smolen A, Kurylcio A, Polkowski W, Lupa-Zatwarnicka K. Bioimpedance vector pattern in women with breast cancer detected by bioelectric impedance vector analysis. Preliminary observations. Ann Agric Environ Med 2012;19:697–700
  6. Park JH, Jo YI, Lee JH. Clinical usefulness of bioimpedance analysis for assessing volume status in patients receiving maintenance dialysis. Korean J Intern Med 2018;33:660–9
  7. Keane D, Gardiner C, Lindley E, Lines S, Woodrow G, Wright M. Changes in Body Composition in the Two Years after Initiation of Haemodialysis: A Retrospective Cohort Study. Nutrients 2016;8:702
  8. Lim PS, Chen CH, Zhu F, Kotanko P, Jeng Y, Hu CY, et al. Validating Body Fat Assessment by Bioelectric Impedance Spectroscopy in Taiwanese Hemodialysis Patients. J Ren Nutr 2017;27:37–44
  9. Huan-Sheng C, Yeong-Chang C, Ming-Hsing H, Fan-Lieh T, Chu-Cheng L, Tsai-Kun W, et al. Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes. Int Urol Nephrol 2016;48:1897–909
  10. Kim YJ, Jeon HJ, Kim YH, Jeon J, Ham YR, Chung S, et al. Overhydration measured by bioimpedance analysis and the survival of patients on maintenance hemodialysis: a single-center study. Kidney Res Clin Pract 2015;34:212–8
  11. Muramatsu M, Tsuchiya A, Ohta S, Iijima Y, Maruyama M, Onodera Y, et al. Measuring body composition using the bio electrical impedance method can predict the outcomes of gemcitabine-based chemotherapy in patients with pancreatobiliary tract cancer. Oncol Lett 2015;10:3535–41
  12. Cotogni P, Monge T, Fadda M, De Francesco A. Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition. BMC Cancer 2018;18:990
  13. Tang PL, Wang HH, Lin HS, Liu WS, Chen LM, Ch